NASDAQ:HSCS
Heart Test Laboratories, Inc.
- Stock
Last Close
3.35
30/08 20:00
Market Cap
2.90M
Beta: -
Volume Today
1.33K
Avg: 108.75K
PE Ratio
−0.23
PFCF: −0.28
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Apr '20 | Apr '21 | Apr '22 | Apr '23 | Apr '24 | ||
|---|---|---|---|---|---|---|
average inventory | 803.89K - | 712.46K 11.37% | 675.25K 5.22% | 314.93M 46,538.75% | ||
average payables | 347.28K - | 515.26K 48.37% | 663.06K 28.68% | 224.41M 33,744.33% | ||
average receivables | 112.96K - | 48.54K 57.03% | 160.85K 231.41% | 159.69K 0.72% | ||
book value per share | 0.04 - | -0.24 705.16% | -0.75 214.39% | 0.03 103.88% | 20.76K 71,578,964.73% | |
capex per share | -0.00 - | -0.00 93.77% | -0.00 169.01% | -0.00 866.89% | 182.84 7,940,257.57% | |
capex to depreciation | -0.18 - | -0.02 88.16% | -0.07 243.31% | -0.68 835.33% | 0.68 199.60% | |
capex to operating cash flow | 0.00 - | 0.00 90.24% | 0.00 82.60% | 0.00 498.11% | -0.01 434.86% | |
capex to revenue | -0.18 - | -0.03 84.38% | -0.13 383.38% | -3.55 2,544.69% | 3.47K 97,578.76% | |
cash per share | 0.06 - | 0.09 45.61% | 0.11 25.83% | 0.21 84.50% | 16.47K 7,888,200.54% | |
days of inventory on hand | 6.73K - | 25.69K 281.63% | 31.19K 21.37% | 88.29K 183.12% | 37.77M 42,671.96% | |
days payables outstanding | 2.82K - | 11.49K 307.70% | 32.14K 179.67% | 82.42K 156.45% | 26.90M 32,538.81% | |
days sales outstanding | 745.98 - | 1.35K 81.07% | 58.94 95.64% | 22.64K 38,303.79% | ||
debt to assets | 0.48 - | 1.60 231.42% | 2.95 84.64% | 0.48 83.85% | 0.11 77.11% | |
debt to equity | 2.99 - | -1.61 153.97% | -1.02 36.88% | 6.79 767.38% | 0.14 97.91% | |
dividend yield | ||||||
earnings yield | -0.28 - | -0.19 32.67% | -0.33 75.84% | -73.06 21,909.22% | -2.03 97.22% | |
enterprise value | 14.12M - | 16.03M 13.53% | 19.04M 18.77% | 6.62M 65.20% | -4.77B 72,085.63% | |
enterprise value over ebitda | -3.78 - | -6.32 67.05% | -4.07 35.60% | -1.09 73.23% | 756.14 69,556.23% | |
ev to operating cash flow | -3.68 - | -6.54 77.77% | -5.22 20.08% | -1.15 78.04% | 0.79 168.47% | |
ev to sales | 219.97 - | 625.97 184.58% | 1.32K 111.57% | 1.29K 2.89% | -256.35K 20,031.50% | |
free cash flow per share | -0.48 - | -0.31 36.31% | -0.45 47.36% | -0.73 62.08% | -17.40K 2,388,715.25% | |
free cash flow yield | -0.28 - | -0.18 36.31% | -0.26 47.36% | -0.86 226.08% | -1.88K 218,357.67% | |
graham net net | -0.08 - | -0.33 332.56% | -0.85 156.05% | -0.10 87.88% | 11.17K 10,846,861.24% | |
graham number | 0.65 - | 1.31 101.85% | 3.08 135.12% | 6.35 106.15% | 2.96K 46,508.67% | |
income quality | 1.01 - | 1.00 0.75% | 0.75 24.53% | 0.91 20.39% | 0.92 1.14% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.17 Infinity% | |
interest coverage | -1.36K - | -19.39 98.57% | -12.67 34.64% | -25.14 98.37% | 17.81 170.84% | |
interest debt per share | 0.12 - | 0.40 239.63% | 0.81 101.73% | 0.23 71.75% | 2.94K 1,291,468.06% | |
inventory turnover | 0.05 - | 0.01 73.80% | 0.01 17.61% | 0.00 64.68% | 0.00 99.77% | |
invested capital | 2.99 - | -1.61 153.97% | -1.02 36.88% | 6.79 767.38% | 0.14 97.91% | |
market cap | 13.67M - | 13.67M 0% | 13.79M 0.87% | 6.72M 51.28% | 3.26M 51.52% | |
net current asset value | -102.50K - | -2.20M 2,045.37% | -6.21M 182.61% | -360.10K 94.21% | 5.17B 1,435,299.32% | |
net debt to ebitda | -0.12 - | -0.93 677.31% | -1.12 20.75% | 0.02 101.39% | 756.66 4,866,500.52% | |
net income per share | -0.48 - | -0.32 32.67% | -0.56 75.84% | -61.74 10,839.88% | -18.74 69.65% | |
operating cash flow per share | -0.48 - | -0.30 36.14% | -0.45 47.32% | -0.73 61.66% | -17.22K 2,371,111.96% | |
payables turnover | 0.13 - | 0.03 75.47% | 0.01 64.24% | 0.00 61.01% | 0.00 99.69% | |
receivables turnover | 0.49 - | 0.27 44.77% | 6.19 2,191.63% | 0.02 99.74% | ||
research and ddevelopement to revenue | 31.79 - | 66.73 109.91% | 208.83 212.97% | 477.84 128.82% | 154.76 67.61% | |
return on tangible assets | -1.96 - | -1.34 31.68% | -2.19 63.61% | -149.32 6,715.10% | -0.00 100.00% | |
revenue per share | 0.01 - | 0.00 60.11% | 0.00 44.35% | 0.00 63.44% | 0.05 8,045.53% | |
roe | -12.15 - | 1.35 111.13% | 0.76 44.07% | -2.13K 281,720.40% | -0.00 100.00% | |
roic | -2.48 - | -1.98 20.24% | -22.56 1,041.44% | -199.90 786.12% | -0.00 100.00% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | 0.04 - | -0.24 705.16% | -0.75 214.39% | 0.03 103.88% | 20.76K 71,578,964.73% | |
stock based compensation to revenue | 2.10 - | 0.96 54.21% | 4.76 393.78% | 48.22 913.21% | 21.78K 45,063.27% | |
tangible asset value | 315.55K - | -1.91M 705.16% | -6.06M 217.13% | 230.56K 103.81% | 5.73B 2,484,342.03% | |
tangible book value per share | 0.04 - | -0.24 705.16% | -0.75 214.39% | 0.03 103.88% | 16.25K 56,032,694.01% | |
working capital | 396.10K - | 392.05K 1.02% | -1.54M 492.73% | 863.69K 156.09% | 5.60B 648,526.94% |
All numbers in USD (except ratios and percentages)